Related Experiment Videos

Methicillin-resistant Staphylococcus pneumonia and underlying asymptomatic sarcoidosis: are they related? A

Deepika Sirohi1, P Sengupta, Harsh Kumar

  • 1Department of Pathology, MH Jalandhar, India.

Indian Journal of Pathology & Microbiology
|June 17, 2010
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) can cause severe pneumonia, often due to Panton-Valentine leukocidin. An unusual case revealed an underlying asymptomatic sarcoidosis.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Rheumatology

Background:

  • Staphylococcus aureus is an uncommon cause of pneumonia.
  • Emerging methicillin-resistant strains (MRSA) are increasingly identified as pathogens.
  • MRSA pneumonia can be rapidly fatal, characterized by hemorrhagic presentation.

Observation:

  • The reported case involved a patient with severe pneumonia.
  • The causative agent was identified as MRSA.
  • The patient's MRSA pneumonia was linked to Panton-Valentine leukocidin production.
  • An unusual co-finding was an asymptomatic, multisystem sarcoidosis.

Findings:

  • MRSA is a significant pathogen in severe pneumonia.
  • Panton-Valentine leukocidin is a key virulence factor in fatal MRSA pneumonia.
  • The co-existence of asymptomatic sarcoidosis with MRSA pneumonia is rare.

Implications:

  • Highlights the critical role of MRSA in severe pneumonia.
  • Underscores the importance of identifying virulence factors like PVL.
  • Suggests potential, yet unexplored, links between sarcoidosis and infectious diseases.
  • Emphasizes the need for comprehensive patient evaluation in complex cases.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...